Siemens offers free posters (above) by simply registering in this page! Just Click here

The ACR and Society of Breast Imaging Statement on Radiation Received to the Thyroid from Mammography

April 4, 2011
Some Americans have expressed concern, due to an erroneous media report, that the small amount of radiation a patient receives from a mammogram may significantly increase the likelihood of developing thyroid cancer. This concern simply is not supported in scientific literature.
The radiation dose to the thyroid from a mammogram is extremely low. The thyroid is not exposed to the direct X-ray beam used to image the breast and receives only a tiny amount of scattered X-rays (less than 0.005 milligray). This is equivalent to only 30 minutes of natural background radiation received by all Americans from natural sources.

NeuroLogica, the company which already delivered a mobile head CT, has now received FDA approval for a portable, full body, multi slice CT scanner, the BodyTom. The BodyTom is a 32 slice CT with a 85cm gantry and 60cm field of view. It can be operated battery powered (up to 12 hours) or plugged into standard wall power outlets. The vision of the company is to bring the CT to the patient instead of vice versa, whether into the clinic, ICU, OR or emergency department. Apart from the increased portability, one of the most interesting new possibilities this brings is intraoperative CT, instead of the good old fluoroscopic imaging, without the need of an expensive dedicated CT-equipped operating room. The following comes from the intraoperative applications feature page:

Click here and watch day by day how radiation was spread all over Europe. Where were you that day??

Λόγω της πληθώρας των ερωτήσεων που μας υποβάλλονται αναφορικά με ενδεχόμενες συνέπειες στη χώρα μας από το ατύχημα στον πυρηνικό σταθμό Fukushima της Ιαπωνίας, τονίζουμε:

• δεν συντρέχει κανένας λόγος ανησυχίας και δεν απαιτείται η λήψη οποιουδήποτε μέτρου προστασίας
• μην αλλάζετε καμία διατροφική ή άλλη συνήθειά σας
• δεν υπάρχει λόγος για χορήγηση ή επάλειψη με ιώδιο
• δεν υπάρχει καμία ανησυχία για ευαίσθητες ομάδες (έγκυοι, παιδιά, μωρά που θηλάζουν)